TEST BANK-
q
Davis Advantage for Psychiatric Mental Health Nursing
q q q q q q
Karyn I. Morgan
q q q
11th Edition
q
, Table qof q Contents
Chapter q01. qThe qConcept qof qStress qAdaptation
Chapter q02. qMental qHealth/Mental qIllness: qHistorical qand qTheoretical
qConcepts q
Chapter q03. qPsychopharmacology
Chapter q04. qConcepts qof qPsychobiology
Chapter q05. qEthical qand qLegal qIssues qin qPsychiatric/Mental qHealth qNursing
Chapter q06. qCultural qand qSpiritual qConcepts qRelevant qto qPsychiatric/Mental qHealth qNursing
qChapter q07. qRelationship qDevelopment
Chapter q08. qTherapeutic qCommunication
Chapter q09. qThe qNursing qProcess qin qPsychiatric/Mental qHealth qNursing
qChapter q10. qTherapeutic qGroups
Chapter q11. qIntervention qWith qFamilies
Chapter q12. qMilieu qTherapy q- qThe qTherapeutic qCommunity
qChapter q13. qCrisis qIntervention
Chapter q14. qAssertiveness qTraining
qChapter q15. qPromoting qSelf-Esteem
Chapter q16. qAnger/Aggression qManagement
qChapter q17. qThe qSuicidal qClient
Chapter q18. qBehavior q Therapy
qChapter q19. qCognitive q Therapy
qChapter q20. qElectroconvulsive
qTherapy qChapter q21. qThe qRecovery
qModel qChapter q22. qNeurocognitive
qDisorders
Chapter q23. q Substance-Related qand qAddictive q Disorders
Chapter q24. qSchizophrenia qSpectrum qand qOther qPsychotic qDisorders
qChapter q25. qDepressive qDisorders
Chapter q26. qBipolar qand qRelated qDisorders
Chapter q27. qAnxiety, qObsessive-Compulsive, qand qRelated qDisorders
qChapter q28: qTrauma qand qStressor-Related qDisorders
Chapter q29. q Somatic qSymptom q and qDissociative qDisorders
Chapter q30. qIssues qRelated qto qHuman qSexuality qand qGender qDysphoria
qChapter q31. qEating qDisorders
Chapter q32. qPersonality qDisorders
qChapter q33. qChildren qand qAdolescents
qChapter q34. qThe qAging qIndividual
Chapter q35. qSurvivors qof qAbuse qor qNeglect
qChapter q36. qCommunity qMental qHealth qNursing
qChapter q37. qThe qBereaved qIndividual
Chapter q38. qMilitary qFamilies
,Chapter 01. Psychopharmacology
q q
Multiple qChoice
1. The qNURSE qmanager qon qthe qpsychiatric qunit qwas qexplaining qto qthe qnew qstaff qthe qdifferences
qbetween qtypical qand qatypical qantipsychotics. qThe qNURSE qcorrectly qstates qthat qatypical
qantipsychotics:
A. Remain qin qthe qsystem qlonger
B. Act qmore qquickly qto qreduce qdelusions
C. Produce qfewer qextrapyramidal qeffects
D. Are qrisk qfree qfor qneuroleptic qmalignant qsyndrome q(NMS)
CORRECT qANSWER:C
Atypical qantipsychotics qproduce qless qD2blockade; qthus qmovement qdisorders qare qless qof qa qproblem. qNo
qevidence qsuggests qthat qthe qmedication qremains qin qthe qsystem qlonger qnor qthat qit qacts qmore qquicklyto qreduce
qdelusions. qThe qatypicals qare qnot qrisk qfree qfor qNMS.
KEY: qCognitive qLevel: qApplication q | qIntegrated qProcesses: qNursing qProcess: qImplementation q| qClient qNeed:
Physiological qIntegrity: qPharmacological qand qParenteral qTherapies
2. The qNURSE qwould qassess qfor qneuroleptic qmalignant qsyndrome q(NMS) qif qa qpatient qon
qhaloperidol q(Haldol) qdevelops qa:
A. 30 qmm qHg qdecrease qin qblood qpressure qreading
B. Respiratory qrate qof q24 qrespirations qper qminute
C. Temperature qreading q of q104° q F
D. Pulse qrate qof q70 qbeats qper qminute
CORRECT qANSWER:C
Increased qtemperature qis qthe qcardinal qsign qof qNMS. qThis qBP qis qnot qa qsignificant qfeature qof qNMS. qThere qare
qno qsignificant qfindings qto qsupport qthe qoptions qrelated qto qrespirations qor qpulse qrate.
KEY: qCognitive qLevel: qApplication q | qIntegrated qProcesses: qNursing qProcess: qAssessment q| qClient qNeed:
Physiological qIntegrity: qPharmacological qand qParenteral qTherapies
3. A qpatient qtaking qfluphenazine q(Prolixin) qcomplains qof qdry qmouth qand qblurred qvision. qWhat qwould qthe
qNURSE qassess qas qthe qlikely qcause qof qthese qsymptoms?
A. Decreased qdopamine qat qreceptor qsites
B. Blockade qof qhistamine
C. Cholinergic qblockade
D. Adrenergic qblocking
CORRECT qANSWER:C
Fluphenazine qadministration qproduces qblockade qof qcholinergic qreceptors qgiving qrise qto qanticholinergic
qeffects, qsuch qas qdry qmouth, qblurred qvision, qand qconstipation.
KEY: qCognitive qLevel: qApplication q | qIntegrated qProcesses: qNursing qProcess: qAssessment q| qClient qNeed:
, Physiological qIntegrity: qPharmacological qand qParenteral qTherapies
q
Davis Advantage for Psychiatric Mental Health Nursing
q q q q q q
Karyn I. Morgan
q q q
11th Edition
q
, Table qof q Contents
Chapter q01. qThe qConcept qof qStress qAdaptation
Chapter q02. qMental qHealth/Mental qIllness: qHistorical qand qTheoretical
qConcepts q
Chapter q03. qPsychopharmacology
Chapter q04. qConcepts qof qPsychobiology
Chapter q05. qEthical qand qLegal qIssues qin qPsychiatric/Mental qHealth qNursing
Chapter q06. qCultural qand qSpiritual qConcepts qRelevant qto qPsychiatric/Mental qHealth qNursing
qChapter q07. qRelationship qDevelopment
Chapter q08. qTherapeutic qCommunication
Chapter q09. qThe qNursing qProcess qin qPsychiatric/Mental qHealth qNursing
qChapter q10. qTherapeutic qGroups
Chapter q11. qIntervention qWith qFamilies
Chapter q12. qMilieu qTherapy q- qThe qTherapeutic qCommunity
qChapter q13. qCrisis qIntervention
Chapter q14. qAssertiveness qTraining
qChapter q15. qPromoting qSelf-Esteem
Chapter q16. qAnger/Aggression qManagement
qChapter q17. qThe qSuicidal qClient
Chapter q18. qBehavior q Therapy
qChapter q19. qCognitive q Therapy
qChapter q20. qElectroconvulsive
qTherapy qChapter q21. qThe qRecovery
qModel qChapter q22. qNeurocognitive
qDisorders
Chapter q23. q Substance-Related qand qAddictive q Disorders
Chapter q24. qSchizophrenia qSpectrum qand qOther qPsychotic qDisorders
qChapter q25. qDepressive qDisorders
Chapter q26. qBipolar qand qRelated qDisorders
Chapter q27. qAnxiety, qObsessive-Compulsive, qand qRelated qDisorders
qChapter q28: qTrauma qand qStressor-Related qDisorders
Chapter q29. q Somatic qSymptom q and qDissociative qDisorders
Chapter q30. qIssues qRelated qto qHuman qSexuality qand qGender qDysphoria
qChapter q31. qEating qDisorders
Chapter q32. qPersonality qDisorders
qChapter q33. qChildren qand qAdolescents
qChapter q34. qThe qAging qIndividual
Chapter q35. qSurvivors qof qAbuse qor qNeglect
qChapter q36. qCommunity qMental qHealth qNursing
qChapter q37. qThe qBereaved qIndividual
Chapter q38. qMilitary qFamilies
,Chapter 01. Psychopharmacology
q q
Multiple qChoice
1. The qNURSE qmanager qon qthe qpsychiatric qunit qwas qexplaining qto qthe qnew qstaff qthe qdifferences
qbetween qtypical qand qatypical qantipsychotics. qThe qNURSE qcorrectly qstates qthat qatypical
qantipsychotics:
A. Remain qin qthe qsystem qlonger
B. Act qmore qquickly qto qreduce qdelusions
C. Produce qfewer qextrapyramidal qeffects
D. Are qrisk qfree qfor qneuroleptic qmalignant qsyndrome q(NMS)
CORRECT qANSWER:C
Atypical qantipsychotics qproduce qless qD2blockade; qthus qmovement qdisorders qare qless qof qa qproblem. qNo
qevidence qsuggests qthat qthe qmedication qremains qin qthe qsystem qlonger qnor qthat qit qacts qmore qquicklyto qreduce
qdelusions. qThe qatypicals qare qnot qrisk qfree qfor qNMS.
KEY: qCognitive qLevel: qApplication q | qIntegrated qProcesses: qNursing qProcess: qImplementation q| qClient qNeed:
Physiological qIntegrity: qPharmacological qand qParenteral qTherapies
2. The qNURSE qwould qassess qfor qneuroleptic qmalignant qsyndrome q(NMS) qif qa qpatient qon
qhaloperidol q(Haldol) qdevelops qa:
A. 30 qmm qHg qdecrease qin qblood qpressure qreading
B. Respiratory qrate qof q24 qrespirations qper qminute
C. Temperature qreading q of q104° q F
D. Pulse qrate qof q70 qbeats qper qminute
CORRECT qANSWER:C
Increased qtemperature qis qthe qcardinal qsign qof qNMS. qThis qBP qis qnot qa qsignificant qfeature qof qNMS. qThere qare
qno qsignificant qfindings qto qsupport qthe qoptions qrelated qto qrespirations qor qpulse qrate.
KEY: qCognitive qLevel: qApplication q | qIntegrated qProcesses: qNursing qProcess: qAssessment q| qClient qNeed:
Physiological qIntegrity: qPharmacological qand qParenteral qTherapies
3. A qpatient qtaking qfluphenazine q(Prolixin) qcomplains qof qdry qmouth qand qblurred qvision. qWhat qwould qthe
qNURSE qassess qas qthe qlikely qcause qof qthese qsymptoms?
A. Decreased qdopamine qat qreceptor qsites
B. Blockade qof qhistamine
C. Cholinergic qblockade
D. Adrenergic qblocking
CORRECT qANSWER:C
Fluphenazine qadministration qproduces qblockade qof qcholinergic qreceptors qgiving qrise qto qanticholinergic
qeffects, qsuch qas qdry qmouth, qblurred qvision, qand qconstipation.
KEY: qCognitive qLevel: qApplication q | qIntegrated qProcesses: qNursing qProcess: qAssessment q| qClient qNeed:
, Physiological qIntegrity: qPharmacological qand qParenteral qTherapies
